Log In
Print this Print this

hGH-NexP (CJ-40002)

  Manage Alerts
Collapse Summary General Information
Company Alteogen Inc.
DescriptionLong-acting human growth hormone fused with a highly glycosylated alpha-1 antitrypsin mutant
Molecular Target
Mechanism of Action 
Therapeutic ModalityPeptide
Latest Stage of DevelopmentPhase I
Standard IndicationGrowth failure
Indication DetailsTreat growth failure
Regulatory Designation
PartnerCJ Group

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today